Journals / Akademik Gıda / 2006 / Cilt: 4 Sayı: 3

RESVERATROL IN WINES: THE EFFECTS ON CORONORY HEART DISEASES AND CANCER

Şaraplarda Resveratrol Bileşiği: Koroner Kalp Hastalıkları ve Kanser Üzerine Etkileri

Ufuk Yücel(Ege Üniversitesi, Ege Meslek Yüksek Okulu, Gıda Teknolojisi Programı)
Eren Akçiçek(Ege Üniversitesi, Tıp Fakültesi, Namık Kemal Menteş Gastroenteroloji Kliniği)
Pages
12–14
Publication Date
2006-06-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

An inverse correlation between consumption of red wine and incidence of cardiovascular diseases led to the concept of the “French paradox”

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Resveratrol is a non-flavonoid polyphenol that has attracted attention as a potential anti-cancer agent.
📊
Key Findings & Data:It has been related with resveratrol the benefits of drinking red wine 1or 2 glasses in a day.
💡
Conclusion & Impact:An inverse correlation between consumption of red wine and incidence of cardiovascular diseases led to the concept of the “French paradox”
🔬Design:Makale
📍Scope:Comprehensive Sample
⚙️Variables:şarap · resveratrol · koroner kalp hastalıkları

Abstract

Resveratrol is a non-flavonoid polyphenol that has attracted attention as a potential anti-cancer agent. On the other hand, it is expressed that coronory heart diseases are prevented by resveratrol. It has been related with resveratrol the benefits of drinking red wine 1or 2 glasses in a day. An inverse correlation between consumption of red wine and incidence of cardiovascular diseases led to the concept of the “French paradox”

Özet

Resveratrol flavonoid olmayan bir polifenol olup, potansiyel bir antikanserojen bileşik olarak değerlendirilmekte bunun yanı sıra söz konusu bileşiğin koroner kalp hastalıklarını önlemede etkili olduğu ifade edilmektedir. Günde 1-2 kadeh kırmızı şarap tüketiminin yararları bu bileşikle ilişkilendirilmiştir. Kırmızı şarap tüketimi ile kardiovasküler hastalıkların oluşumu arasındaki ters orantı Fransız paradoksu olarak tanımlanmaktadır

🔖

Cite This Article

Yücel, U., Akçiçek, E. (2006). RESVERATROL IN WINES: THE EFFECTS ON CORONORY HEART DISEASES AND CANCER. Akademik Gıda, Cilt: 4 Sayı: 3, 12–14. https://ajindex.com/articles/1357719

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (46)

  1. Nonomura, S., Kanagawa, H. & Makimoto, A. 1963. Chemical
  2. constituents of polygonaceus plants. Studies on the components of Ko-jokan
  3. (Polyganum Cuspidatum SIEB et zucc). Yakugaku Zasshi, 83:983-988. 25. Aktan, N. 2000. Bir yudum şarap. Doğa Ofset, 48 sayfa. 26. Bisson, L. F., Butzke, C. E. & Ebeler, S. E. 1995. The role of moderate ethanol consumption in health and human nutrition. American Journal of Tissue Reaction, 17, 1-3.
  4. A comparison of four red wine polyphenols. Clinical biochemistry, 35, 119- 124. 27. Blond, J., Denis, M. & Bezard, J. 1995. Antioxidant action of resveratrol in lipid peroxidation. Sciences des Aliments, 15, 347-358.
  5. Langcake, P. & Pryce, R. J. 1976. The production of resveratrol by Vitis
  6. vinifera and other members of the Vita ceae as a response to infection or injury.
  7. Physiol plant., Pathol. 9:77-86. 28. Demrow, H. S., Slane, P. R. & Flots, J. D. 1995. Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronory arteries, Circulation, 91, 1182-1188.
  8. Siemann, H.E. & Creasy. L. L. 1992. Concentration of the phytoalexin
  9. resveratrol in wine. American Journal of Enology and Viticulture, 43, 49-52. 29. Fittzpatrick, D. E., Hirschfield, S. L. & Coffey, R. G. 1993. Endothelium- dependent vasorelex-ing activity of wine, grapes and other plant products. American Journal of Physiology, 265, H774-H778.
  10. Improvement on enzymatic hydrolysis of resveratrol glucosides in wine.
  11. Food Chem., 42; 2077-2083. 30. Frankel, E. N., Kanner, J., German, J. B., Parks, E. & Kinsella, J. E. 1993. Inhibition of oxidation of human low density lipoprotein by phenolic substances in red wine, Lancet. 341:454-457.
  12. Goldberg, D. M., Yan, J., Ng. E., Diamandis, E. P., Karumanchiri, A.
  13. Soleas, G. & Waterhouse, A. L. 1995. A global survey of trans-resveratrol
  14. concentrations im commercial wines. American Journal of Enology and Viticulture, 46, 159-165. 31. Fuhrman, B., Lavy, A. & Aviram, M. 1995. Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein peroxidation. American Journal of Clinical Nutrition, 61, 549-554.
  15. Soleas, G. J., Diamandis, E.P. & Goldberg. D. M. 1997. Clinical
  16. biochemistry, 30:91-113. 32. Rimm, E. B., Giovannocci, E.L., Willett, W. C., Colditz, G. A., Ascherio, A., Rosner, B. & Stampfer, M. J. 1991. Prospective study of alcohol consuption and risk of coronary disease in men. Lancet, 338, 464-468.
  17. Lopez-Velez, M., Martinez-Martinez, F. & Del Valle-Ribes, C. 2003. The
  18. study of phenolic compounds as natural antioxidants in wine. Critical Reviews in
  19. Food Science and Nutrition, 43(3): 233-244. 33. Seigneur, M., Bonnet, J., Dorian, B., Benchimol, D., Drouillet, F., Gouverneur, G., Larrue, J., Crockett, R., Boisseau, M., Ribereau-Gayon, P. & Bricaud, H. 1990. Effect of the consumption of alcohol, white wine and red wine on platelet function and serum lipids. Journal of applied and Viticulture, 43, 49-52.
  20. De Santi, C., Pietrabissa, A., Spisni, R., Mosca, F. & Pacifici, G. M.
  21. Sulphation of resveratrol a natural compoundpresent in wine and its
  22. inhibition by natural favonoids. Xenobiotica, Vol: 30. No: 9, 857-866. 34. Ferraroni, M., Decarli., Franceschi, S. 1996. Validity and reproducibility of alcohol consumption in Italy. Int. J. Epidemiol., 25:775-82.
  23. Vrhovsek, U., Wendelin, S. & Eder, R. 1997. Effects of various vinification
  24. techniques on the concentration of cis- and trans resveratrol and resveratrol
  25. glucoside isomers in wine. American Journal of Enology and Viticulture, 48, 214 219. 35. St Leger, A. S., Cochrana, A. L. & Moore, F. 1979. Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet., 1017-1020. 36. Bertelli, A. A., Giovannini, l., Gianessi, D., Migliori, M., Bernini. W., Fregoni, M. & Bertelli, A. 1995. Antiplatelet activity of synthetic and natural rsveratrol in red wine. International Journal of Enology and Viticulture, 38, 65-68.
  26. determination of cis and trans-resveratrol in wines by capillary zone
  27. electrophoresis. Analyst., 124, 61-66. 37. Hertog, M. G. L., Hollman, P.C.H. & Katan, M. B. 1992. Content of potentially anticarcinogenic flavonoids of 28 vegetables and nine fruits commonly consumed in the Netherlands. J. Agric.Food Chem., 40: 2379-83.
  28. isomers in commercially available wines made from grapes cultivated in Japan.
  29. Bioscience Biotechnology and Bichemistry, 61, 1800-1805. 38. Hollman, P. C. & Katan, M. B. 1997. Absorbtion, metabolism and health effects of dietary flavonoids. in. Man. Biomed Pharmacother, 51:305-10.
  30. compounds from the grape wine to wine. Drugs under Experimental and Clinical
  31. Research, 25, 57-63. 39. Landofi, R., Moer, R. & Steiner, M. 1984. Modification of platelet function and arachidonic acid metabolism by flavonoids. Biochemistry Pharmacology, 33:1525-1530.
  32. sefence mechanisms. Tansley Review. No.72, New Phytologist., 127, 617-633.
  33. Fremont, L. 1999. Biological effects of resveratrol. Life Sciences, Vol.66, No.8, 663-673. 40. Subbarrmaiah, K., Chung, W. J., Michaluart, P., Telang, N., Tanabe, T. & Inoue, H. 1998. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J. Biol. Chem., 273: 21875-82.
  34. Yücel, U. 2000. Geleneksel şarap üretiminde ekolojik yaklaşımlar. Dünya Gıda Ocak, 54-55. 41. Maccarrone, M., Lorenzon, T. & Guerrieri, P. 1999. Resveratrol prevents apontosis in K562 cells by inhibiting lipoxygenase activity. Eur. J. Biochem., 265: 27-34.
  35. wine by capillary electrophoresis. Journal of Chromatography A, 881, 471-481.
  36. Romero- Perez, A. I., Lamuela- Raventos, R. M., C, Andres Lacueva
  37. C. & de La Torre- Boronat, M. C. 2001. Method for the quantitative extraction
  38. of resveratrol and piceid isomers in grape berry skins. Effect of powdery mildew on
  39. Chemistry, 76, 371-375
  40. Tinttunen, S. & Lehtonen, P. 2001. Distinguishing organic wines from
  41. normal wines on the basis of concentrations of phenolic compounds and spectral
  42. data. Eur Food Res. Technol., 212;390-394
  43. Savouret, J.F & Quesne. M. 2002. Resvereatrol and Cancer: A review.
  44. Biomed Pharma cother, 56: 84-87.
  45. glucoside isomers in wine. American Journal of Enology and Viticulture, 48, 214 219. 35. St Leger, A. S., Cochrana, A. L. & Moore, F. 1979. Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet., 1017-1020. 36. Bertelli, A. A., Giovannini, l., Gianessi, D., Migliori, M., Bernini. W., Fregoni, M. & Bertelli, A. 1995. Antiplatelet activity of synthetic and natural rsveratrol in red wine. International Journal of Enology and Viticulture, 38, 65-68.
  46. compounds from the grape wine to wine. Drugs under Experimental and Clinical